title: Ex vivo gene therapy to produce bone using different cell types.
abstract: Gene therapy and tissue engineering promise to revolutionize orthopaedic surgery. This study comprehensively compares five different cell types in ex vivo gene therapy to produce bone. The cell types include a bone marrow stromal cell line, primary muscle derived cells, primary bone marrow stromal cells, primary articular chondrocytes, and primary fibroblasts. After transduction by an adenovirus encoding for bone morphogenetic protein-2, all of the cell types were capable of secreting bone morphogenetic protein-2. However, the bone marrow stromal cell line and muscle derived cells showed more responsiveness to recombinant human bone morphogenetic protein-2 than did the other cell types. In vivo injection of each of the cell populations transduced to secrete bone morphogenetic protein-2 resulted in bone formation. Radiographic and histologic analyses corroborated the in vitro data regarding bone morphogenetic protein-2 secretion and cellular osteocompetence. This study showed the feasibility of using primary bone marrow stromal cells, primary muscle derived cells, primary articular chondrocytes, primary fibroblasts, and an osteogenesis imperfecta stromal cell line in ex vivo gene therapy to produce bone. The study also showed the advantages and disadvantages inherent in using each cell type.
authors.affiliation: Department of Orthopaedic Surgery, University of Pittsburgh, PA, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Musgrave
authors.forename: P
authors.initials: P
authors.lastname: Bosch
authors.forename: J Y
authors.initials: JY
authors.lastname: Lee
authors.forename: D
authors.initials: D
authors.lastname: Pelinkovic
authors.forename: S C
authors.initials: SC
authors.lastname: Ghivizzani
authors.forename: J
authors.initials: J
authors.lastname: Whalen
authors.forename: C
authors.initials: C
authors.lastname: Niyibizi
authors.forename: J
authors.initials: J
authors.lastname: Huard
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D001854:Bone Marrow Cells / Q000502:physiology; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000378:metabolism / Q000502:physiology*; D002478:Cells, Cultured; D004797:Enzyme-Linked Immunosorbent Assay; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D051379:Mice; D018482:Muscle, Skeletal / Q000166:cytology; D010012:Osteogenesis / Q000502:physiology*; D011817:Rabbits; D017154:Stromal Cells / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000378:metabolism / Q000502:physiology*
chemical_list: C525718:BMP2 protein, human; C525719:Bmp2 protein, mouse; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D016212:Transforming Growth Factor beta